AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30786339 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 h enteral nutrition group (group A)
Number of subjects: 50
Study 30786339 — intervention group
Group type: COMPARATOR
Intervention: 48 h enteral nutrition group (group B)
Number of subjects: 50
Study 30786339 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study 29130496 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 150
Study 29130496 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditative practices
Number of subjects: 150
Study 29130496 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional reflexology
Number of subjects: 150
Study 29130496 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional meditative practices
Number of subjects: 150
Study 29130496 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 25472509 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation approaches of the Chronic Care Model
Number of subjects: 822
Study 25472509 — intervention group
Group type: EXPERIMENTAL
Intervention: High vs. low practice Change Culture
Number of subjects: 822
Study 25472509 — intervention group
Group type: EXPERIMENTAL
Intervention: High vs. low practice Work Culture
Number of subjects: 822
Study 25472509 — intervention group
Group type: EXPERIMENTAL
Intervention: High vs. low variability in practice Change Culture
Number of subjects: 822
Study 25472509 — intervention group
Group type: EXPERIMENTAL
Intervention: High vs. low variability in practice Work Culture
Number of subjects: 822
Study 23750422 — intervention group
Group type: EXPERIMENTAL
Intervention: Special effect San Xiao decoction (1 dose/d for 12 weeks)
Number of subjects: 116
Study 23750422 — intervention group
Group type: COMPARATOR
Intervention: Metformin (0.5 g/time, oral, 2 times/d)
Number of subjects: 116
Study 21330278 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR + CB (4 IVR calls during the first month postdischarge)
Number of subjects: 738
Study 21330278 — intervention group
Group type: COMPARATOR
Intervention: IVR (1 IVR call at 2 weeks postdischarge)
Number of subjects: 738
Study 21330278 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR + CB
Number of subjects: 738
Study 19261138 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician aware of BNP levels (BNP group)
Number of subjects: 92
Study 19261138 — intervention group
Group type: COMPARATOR
Intervention: Blinded to BNP levels (control group)
Number of subjects: 92
Study 19261138 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BNP and control)
Number of subjects: 92
Study 16872965 — intervention group
Group type: EXPERIMENTAL
Intervention: No-touch technique (veins removed with surrounding tissue, not distended, stored in heparinized blood)
Number of subjects: 104
Study 16872965 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (veins stripped, distended, stored in saline solution)
Number of subjects: 104
Study 16872965 — intervention group
Group type: EXPERIMENTAL
Intervention: No-touch technique
Number of subjects: 104
Study 16872965 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 104
Study 12611783 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA (60 g)
Number of subjects: 25
Study 12611783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 10848659 — intervention group
Group type: EXPERIMENTAL
Intervention: OMC (omeprazole 20 mg b.d., metronidazole 400 mg b.d., clarithromycin 250 mg b.d.)
Number of subjects: 220
Study 10848659 — intervention group
Group type: COMPARATOR
Intervention: OAM (omeprazole 40 mg mane, amoxycillin 500 mg t.d.s., metronidazole 400 mg t.d.s.)
Number of subjects: 220
Study 9122729 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose recombinant interferon alfa-2b (rIFN‐alpha 2b)
Number of subjects: 0
Study 9122729 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study 8484286 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 600
Study 8484286 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 600
Study 3094430 — intervention group
Group type: EXPERIMENTAL
Intervention: Varied harmonic environment
Number of subjects: 0
Study 3094430 — intervention group
Group type: COMPARATOR
Intervention: Quiet ambient environment
Number of subjects: 0
Study 30833435 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive sentinel lymph node (SLN) with micrometastases
Number of subjects: 139
Study 30833435 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive sentinel lymph node (SLN) with macrometastases
Number of subjects: 139
Study 30833435 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative lymph nodes (sentinel or non-sentinel)
Number of subjects: 139
Study 30833435 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated tumor cells on lymph nodes
Number of subjects: 139
Study 30833435 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients aged >50 years
Number of subjects: 139
Study 29316883 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care intervention delivered over 5 months with a minimum of 7 clinical contacts.
Number of subjects: 0
Study 29316883 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care intervention components: weak opioid, laxatives, discussion about spiritual worries, emotional support, time to talk about worries, discussion about future and planning ahead.
Number of subjects: 0
Study 29316883 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative findings from the intervention group.
Number of subjects: 0
Study 26241790 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 331
Study 26241790 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections (MDI)
Number of subjects: 331
Study 26241790 — intervention group
Group type: EXPERIMENTAL
Intervention: CSII
Number of subjects: 331
Study 26241790 — intervention group
Group type: COMPARATOR
Intervention: MDI
Number of subjects: 331
Study 24450776 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump therapy
Number of subjects: 196
Study 23171804 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐in‐6 double catheter technique (DC group)
Number of subjects: 187
Study 23171804 — intervention group
Group type: COMPARATOR
Intervention: Conventional buddy‐wire or balloon‐anchoring approach (control group)
Number of subjects: 187
Study 21141772 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio modeling only
Number of subjects: 0
Study 21141772 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio and visual modeling
Number of subjects: 0
Study 21141772 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 21141772 — intervention group
Group type: EXPERIMENTAL
Intervention: Musically trained participants
Number of subjects: 0
Study 21141772 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmusically trained participants
Number of subjects: 0
Study 17646228 — intervention group
Group type: EXPERIMENTAL
Intervention: IV prednisolone, 60 mg for 5 days
Number of subjects: 210
Study 17646228 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone, 60 mg for 5 days
Number of subjects: 210
Study 14694036 — intervention group
Group type: EXPERIMENTAL
Intervention: neurofilament light protein (NFL)
Number of subjects: 66
Study 14694036 — intervention group
Group type: EXPERIMENTAL
Intervention: glial fibrillary acidic protein (GFAP)
Number of subjects: 66
Study 14694036 — intervention group
Group type: COMPARATOR
Intervention: S100B
Number of subjects: 66
Study 14694036 — intervention group
Group type: COMPARATOR
Intervention: neuron‐specific enolase protein (NSE)
Number of subjects: 66
Study 10691224 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐ml lidocaine‐epinephrine test dose + 12 ml bupivacaine, 0.0625%
Number of subjects: 60
Study 10691224 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐ml lidocaine‐epinephrine test dose + 12 ml bupivacaine, 0.125%
Number of subjects: 60
Study 10691224 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 ml bupivacaine, 0.0625% (no test dose)
Number of subjects: 60
Study 10691224 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 ml bupivacaine, 0.125% (no test dose)
Number of subjects: 60
Study 10691224 — intervention group
Group type: COMPARATOR
Intervention: All groups (including both test dose and no test dose)
Number of subjects: 60
Study 9233096 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial (TA) technique
Number of subjects: 57
Study 9233096 — intervention group
Group type: COMPARATOR
Intervention: Peripheral nerve stimulator (PNS) technique
Number of subjects: 57
Study 9233096 — intervention group
Group type: COMPARATOR
Intervention: Both techniques (TA and PNS)
Number of subjects: 57
Study 8140383 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 micrograms) aqueous nasal spray (FPANS) twice daily
Number of subjects: 251
Study 8140383 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (200 micrograms) aqueous nasal spray (BDPANS) twice daily
Number of subjects: 251
Study 8140383 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 micrograms) aqueous nasal spray (FPANS) and Beclomethasone dipropionate (200 micrograms) aqueous nasal spray (BDPANS)
Number of subjects: 251
Study 3945437 — intervention group
Group type: EXPERIMENTAL
Intervention: melphalan, 5-fluorouracil, and medroxyprogesterone acetate with or without tamoxifen
Number of subjects: 50
Study 30039776 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin used by 11/14 centres in 25% of patients (23-31%)
Number of subjects: 397
Study 30039776 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidirectional Glenn procedure
Number of subjects: 397
Study 30039776 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep hypothermic circulatory arrest
Number of subjects: 397
Study 30039776 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU length of stay
Number of subjects: 397
Study 30039776 — intervention group
Group type: EXPERIMENTAL
Intervention: Total length of stay
Number of subjects: 397
Study 27232052 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilazodone 20-40 mg/d
Number of subjects: 400
Study 27232052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 24853923 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic spine manipulation (TSM)
Number of subjects: 97
Study 24853923 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 97
Study 22410375 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacetylmorphine
Number of subjects: 0
Study 22410375 — intervention group
Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 0
Study 20189517 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC) in addition to biofeedback therapy (BT)
Number of subjects: 24
Study 20189517 — intervention group
Group type: COMPARATOR
Intervention: Standard care only (biofeedback therapy [BT])
Number of subjects: 24
Study 18180641 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Indicators of Infant Pain (BIIP) scale during blood collection (procedure A)
Number of subjects: 69
Study 18180641 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Indicators of Infant Pain (BIIP) scale during blood collection preceded by a diaper change (procedure B)
Number of subjects: 69
Study 18180641 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate (HR) during blood collection (procedure A)
Number of subjects: 69
Study 18180641 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate (HR) during blood collection preceded by a diaper change (procedure B)
Number of subjects: 69
Study 18180641 — intervention group
Group type: COMPARATOR
Intervention: Heart Rate (HR) during Lance phase between procedure A and B
Number of subjects: 69
Study 16194181 — intervention group
Group type: EXPERIMENTAL
Intervention: Posturing face down following macular hole surgery
Number of subjects: 18
Study 16194181 — intervention group
Group type: COMPARATOR
Intervention: Two different posturing regimes
Number of subjects: 18
Study 12853795 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum protein profiling by surface enhanced laser desorption/ionization time of flight mass spectrometry
Number of subjects: 106
Study 12853795 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spectral data from the weak cation exchange and copper metal affinity capture arrays
Number of subjects: 106
Study 10371089 — intervention group
Group type: EXPERIMENTAL
Intervention: Active SIT with allergoid extract of Parietaria pollen
Number of subjects: 0
Study 10371089 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (switched to active SIT after year 1)
Number of subjects: 0
Study 8814688 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin and etoposide (EP) combined with cranial and local radiotherapy
Number of subjects: 202
Study 8814688 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy with vincristine, doxorubicin and cyclophosphamide (VAC)
Number of subjects: 202
Study 8814688 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy with VAC
Number of subjects: 202
Study 8814688 — intervention group
Group type: COMPARATOR
Intervention: Overall survival (OS) and disease-free survival (DFS)
Number of subjects: 202
Study 8814688 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction regimen (EP combined with radiotherapy)
Number of subjects: 202
Study 2005223 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive oral hygiene instructions, scaling and root planing (OH group)
Number of subjects: 27
Study 2005223 — intervention group
Group type: COMPARATOR
Intervention: No treatment (no treatment group)
Number of subjects: 27
Study 6152739 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 118.551 (50 or 100 mg t.i.d.)
Number of subjects: 15
Study 6152739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31420360 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (experimental arm with altered fractionation and/or multiagent concurrent systemic therapy)
Number of subjects: 2688
Study 29544423 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation (CR)
Number of subjects: 28
Study 29544423 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 28
Study 26700487 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based motivational enhancement intervention
Number of subjects: 422
Study 26700487 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 422
Study 24383505 — intervention group
Group type: EXPERIMENTAL
Intervention: β-alanine supplementation
Number of subjects: 25
Study 24383505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 21742531 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple drilling combined with alendronate
Number of subjects: 93
Study 21742531 — intervention group
Group type: COMPARATOR
Intervention: Multiple drilling alone
Number of subjects: 93
Study 19708633 — intervention group
Group type: EXPERIMENTAL
Intervention: Locked plating
Number of subjects: 58
Study 19708633 — intervention group
Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 58
Study 17697218 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal LMA
Number of subjects: 100
Study 17697218 — intervention group
Group type: COMPARATOR
Intervention: Tracheal tube
Number of subjects: 100
Study 12925469 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane/remifentanil (<=0.1 microg kg(‐1) min(‐1))
Number of subjects: 40
Study 12925469 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane/remifentanil (>=0.2 microg kg(‐1) min(‐1))
Number of subjects: 40
Study 12925469 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol/remifentanil (<=0.1 microg kg(‐1) min(‐1))
Number of subjects: 40
Study 12925469 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol/remifentanil (>=0.2 microg kg(‐1) min(‐1))
Number of subjects: 40
Study 12925469 — intervention group
Group type: COMPARATOR
Intervention: BIS
Number of subjects: 40
Study 12925469 — intervention group
Group type: COMPARATOR
Intervention: PSI
Number of subjects: 40
Study 11058007 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal participants performing with maximum effort
Number of subjects: 0
Study 11058007 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants faking hand weakness
Number of subjects: 0
Study 11058007 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients recovering from carpal tunnel surgery
Number of subjects: 0
Study 8877887 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidose nebulizer (200 x 15 microL doses of flunisolide, 250 micrograms)
Number of subjects: 10
Study 8877887 — intervention group
Group type: COMPARATOR
Intervention: Pressurized metered dose inhaler (MDI, 250 micrograms of flunisolide)
Number of subjects: 10
Study 8877887 — intervention group
Group type: COMPARATOR
Intervention: MDI plus Inhacort spacer (250 micrograms of flunisolide)
Number of subjects: 10
Study 8877887 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidose nebulizer
Number of subjects: 10
Study 8877887 — intervention group
Group type: COMPARATOR
Intervention: MDI
Number of subjects: 10
Study 8877887 — intervention group
Group type: COMPARATOR
Intervention: MDI plus Inhacort spacer
Number of subjects: 10
Study 1642345 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (1 mg in 20 ml NaCl)
Number of subjects: 33
Study 1642345 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (20 ml, 0.25%)
Number of subjects: 33
Study 1642345 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of morphine and bupivacaine
Number of subjects: 33
Study 6134536 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium 0.08 mg kg‐1
Number of subjects: 20
Study 6134536 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium 0.057 mg kg‐1
Number of subjects: 20
Study 31200685 — intervention group
Group type: EXPERIMENTAL
Intervention: La Vida Buena (LVB) 8-week family-focused intervention
Number of subjects: 0
Study 31200685 — intervention group
Group type: COMPARATOR
Intervention: Single educational session
Number of subjects: 0
Study 27444007 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ocriplasmin (0.1 ml)
Number of subjects: 39
Study 27444007 — intervention group
Group type: COMPARATOR
Intervention: Transconjunctival vitrectomy
Number of subjects: 39
Study 27444007 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ocriplasmin
Number of subjects: 39
Study 26280786 — intervention group
Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF) + Ribavirin (RBV)
Number of subjects: 100
Study 26280786 — intervention group
Group type: COMPARATOR
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF)
Number of subjects: 100
Study 26280786 — intervention group
Group type: COMPARATOR
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF) without Ribavirin (RBV)
Number of subjects: 100
Study 23486618 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided (US) facet joint injections
Number of subjects: 40
Study 23486618 — intervention group
Group type: COMPARATOR
Intervention: Computed Tomography (CT)-controlled interventions
Number of subjects: 40
Study 23486618 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (US and CT)
Number of subjects: 40
Study 21859789 — intervention group
Group type: EXPERIMENTAL
Intervention: ROCsafeRX (minimized perfusion circuits)
Number of subjects: 500
Study 21859789 — intervention group
Group type: COMPARATOR
Intervention: Standard cardiopulmonary bypass
Number of subjects: 500
Study 19220605 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 97
Study 19220605 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 97
Study 16698524 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac patch
Number of subjects: 120
Study 16698524 — intervention group
Group type: COMPARATOR
Intervention: Standard skin medication (placebo; control group)
Number of subjects: 120
Study 15637637 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine IR (n = 17)
Number of subjects: 32
Study 15637637 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 15)
Number of subjects: 32
Study 10234578 — intervention group
Group type: EXPERIMENTAL
Intervention: Gross motor activity program (15-20 minutes/day, 5 days/week)
Number of subjects: 72
Study 10234578 — intervention group
Group type: COMPARATOR
Intervention: Fine motor activity program
Number of subjects: 72
Study 10234578 — intervention group
Group type: EXPERIMENTAL
Intervention: Gross motor activity program (compliant infants)
Number of subjects: 72
Study 10234578 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake (moderately high)
Number of subjects: 72
Study 10234578 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake (low)
Number of subjects: 72
Study 9495784 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunological and antiviral treatment (SRE, Moroxidin, Antiherpin)
Number of subjects: 2
Study 9495784 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic therapy only (Control group)
Number of subjects: 2
Study 1807871 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 25
Study 1807871 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 25
Study 1807871 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 25
Study 6887843 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer Test (TT)
Number of subjects: 211
Study 6887843 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin(ogen) degradation products (FDP)
Number of subjects: 211
Study 6887843 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol Gelatin Test (EGT)
Number of subjects: 211
Study 30336373 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe anxiety
Number of subjects: 244
Study 30336373 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe depression
Number of subjects: 244
Study 30336373 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe cognitive impairments
Number of subjects: 244
Study 30336373 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing tobacco
Number of subjects: 244
Study 30336373 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 244
Study 30336373 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative perception about elderly-friendly society
Number of subjects: 244